Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor
- 1 August 1994
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 30 (1) , 105-115
- https://doi.org/10.1016/0360-3016(94)90525-8
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Synthesis of .omega.-(aminoalkyl)-1,2-closo-dicarbadodecaboranes(12)Inorganic Chemistry, 1992
- Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancerBiology of the Cell, 1992
- EGF induces cell cycle arrest of A431 human epidermoid carcinoma cellsJournal of Cellular Physiology, 1986
- MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGFBiochemical and Biophysical Research Communications, 1985
- Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cellsJournal of Neuroscience Research, 1982
- Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxicCell, 1980
- L-carboranylalanine substituted TMV, a highly boron labeled virus as a model for slow neutron therapy of tumorsJournal of Labelled Compounds and Radiopharmaceuticals, 1978
- Preparation and properties of a soluble trypsin-dextran conjugateCellular and Molecular Life Sciences, 1975
- Boron Neutron Capture Therapy of Cerebral GliomasOncology, 1975
- THE USE OF DEXTRAN IN THE TREATMENT OF BLOOD LOSS AND SHOCKThe Lancet Healthy Longevity, 1952